Stroke Trials in Frankfurt, Germany
Conditions / Stroke / Frankfurt, Germany
Research into Stroke spans multiple therapeutic approaches and trial phases.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04394546 | CHAMPION-AF Clinical Trial | ACTIVE_NOT_RECRUITING | NA |
| NCT04045665 | Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | RECRUITING | PHASE3 |
| NCT00091949 | Insulin Resistance Intervention After Stroke Trial | COMPLETED | PHASE3 |
| NCT02447081 | Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) | COMPLETED | — |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT04226547 | Amplatzer Amulet LAAO vs. NOAC | ACTIVE_NOT_RECRUITING | NA |
| NCT00716079 | The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial | COMPLETED | NA |
| NCT01225562 | Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin | COMPLETED | PHASE3 |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT02239120 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | COMPLETED | PHASE3 |